An efficacy trial of mobile technology for reducing and preventing adolescent suicide

Active Project Grant Awarded Last action

Award ID
R42MH125691
Recipient
Awarding agency
Obligated
$4,860,718

Award facts

Assistance listing
93.242 Mental Health Research Grants
Completion date 91% complete
Originally
Place of performance
New Haven, CT 06511, USA

Award details come from USAspending.gov.

Description

Abstract
Suicide is a leading cause of death in the US and suicide rates have steadily increased. Despite this, there is a paucity of interventions that reduce suicide ideation and behavior. In this project, we seek to enhance a beta version of our suicide prevention digital therapeutic (developed in phase I) and conduct a randomized controlled trial to evaluate the efficacy of the digital therapeutic for suicide-related outcomes. This project will contribute to our understanding of the use of mobile technology as a suicide prevention tool.

Transactions

Action Obligated Date
Amendment $0
Amendment $0
Amendment $596,110
Amendment $596,110
Amendment $0
Amendment $0
Amendment $0
Amendment $671,335
Amendment -$671,335
Amendment $671,335
Amendment -$671,335
Amendment -$671,335
Amendment $671,335
Amendment $0
Amendment $0
Amendment $0
Amendment $125,443
Amendment $125,443
Amendment $125,443
Amendment $125,443
Amendment $480,049
Amendment $480,049
Amendment $480,049
Amendment $480,049
Amendment $480,049
Original award $766,481
Show all 26

Quick answers

Who received award R42MH125691?

R42MH125691 was awarded to OUI Therapeutics Inc. by National Institute of Mental Health (National Institutes of Health) on March 16, 2023.

How much is award R42MH125691 worth?

$4,860,718 has been obligated on R42MH125691.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award